Markets:

Overview

News

Currencies

International

Treasuries

SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

7.110 +0.390 (+5.80%)

Streaming Delayed Price Updated: 12:25 PM EDT, Aug 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SciSparc Ltd. - Ordinary Shares

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Why A National Cannabis Organization Sacked Half Its Staff, CEO Turnovers And More Exec Changes ↗

June 05, 2023

NCIA Sacks Half Of Its Team To Increase Financial Strength

Via Benzinga

Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 02, 2023

Gainers MultiMetaVerse Holdings Limited (NASDAQ: MMV) gained 236% to $3.1592 after the company announced it signed a non-binding term sheet to acquire an equity stake in Taomee group.

Via Benzinga

Update: SciSparc To Spin Off Pharmaceutical Activities Into New Subsidiary ↗

March 01, 2023

The jury is out on how well SciSparc will do in executing its restructuring plan, but the company has no other choice.

Via Talk Markets

New Drug Based On FDA-Approved Synthetic THC And CannAmide Shows Promise In Treating Agitation In Alzhemier's ↗

June 02, 2023

SciSparc Ltd.

Via Benzinga

SciSparc Announces Successful Final Phase IIa Results, Meeting End Points of its Phase IIa Alzheimer Disease Patients with Agitation Trial

June 02, 2023

Topline results using the Company's SCI-110 met the trial’s primary and secondary end points, demonstrating high safety profile and reduced agitation

From SciSparc Ltd

Via GlobeNewswire

SciSparc Makes Another Step Towards Unlocking Potential Value Appoints New Strategy and Business Development VP

May 30, 2023

From SciSparc Ltd

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

May 08, 2023

Pre-market stock movers are a hot topic on Monday as we dive into the biggest winners and losers traders need to know about this morning!

Via InvestorPlace

SciSparc's Drug Discovery Joint Venture MitoCareX Bio Successfully Developed its Core Algorithm to allow suitable Modelling of Human Mitochondrial Carriers for Accelerating its Cancer Drug Discovery Program

May 08, 2023

From SciSparc Ltd

Via GlobeNewswire

SciSparc Completed Treatment of Last Patient Enrolled for its Phase IIa Clinical Trial for Alzheimer's Disease and Agitation

May 02, 2023

From SciSparc Ltd

Via GlobeNewswire

Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More ↗

April 24, 2023

LSD Trial Study Shows Potential For Major Depression Psychedelics biopharma company Mind Medicine Inc. (NASDAQ: MNMD) recently shared positive topline data from an advanced clinical trial of LSD as a...

Via Benzinga

Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 21, 2023

Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.

Via Benzinga

SciSparc And Clearmind Collaboration Strengthens IP Portfolio With Patent Application For Treatment Of Depression ↗

April 21, 2023

SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced that as part of its...

Via Benzinga

Clearmind Medicine Expanding IP Portfolio with New US Patent Application for Treatment of Depression

April 21, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Patent Application in the U.S. for Treatment of Depression

April 21, 2023

From SciSparc Ltd

Via GlobeNewswire

Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 11, 2023

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 164% to $3.86 after the company announced it launched ChatGPT-enabled smart eyewear.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 11, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on Tuesday!

Via InvestorPlace

SciSparc Receives Final Approval to Commence its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome

April 04, 2023

From SciSparc Ltd

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Friday ↗

March 31, 2023

On Friday, 93 stocks made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 28, 2023

During Tuesday, 95 stocks hit new 52-week lows.

Via Benzinga

SciSparc completes the sale of a 49% interest in its Subsidiary that owns Wellution for $3 million

March 28, 2023

From SciSparc Ltd

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

March 27, 2023

Welcome back and get ready for another day of trading with a breakdown of the biggest pre-market stock movers for Monday!

Via InvestorPlace

SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification

March 10, 2023

From SciSparc Ltd

Via GlobeNewswire

SciSparc Receives Approval to conduct its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome

March 09, 2023

From SciSparc Ltd

Via GlobeNewswire

SciSparc Completes Production Of Its Dronabinol-Based Drug Candidate For Its Clinical Trial On Tourette Syndrome ↗

March 06, 2023

SciSparc Ltd. (NASDAQ: SPRC) has successfully manufactured clinical batches of its drug candidate SCI-110 to be used in its upcoming multinational, multicenter, phase IIb trial for Tourette syndrome.

Via Benzinga

SciSparc Successfully Completed Production of its Proprietary Drug Candidate SCI-110 for its Upcoming Clinical Trial On Tourette Syndrome

March 06, 2023

From SciSparc Ltd

Via GlobeNewswire

Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More ↗

February 27, 2023

Two Bills Approved By Hawaii Senators With Governor's Endorsement Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and...

Via Benzinga

SciSparc's CBD-Based Drug One Step Closer To Clinical Trial On Children With Autism Spectrum Disorder ↗

February 27, 2023

SciSparc Ltd. (NASDAQ: SPRC) has signed an agreement with Israel's manufacturer and distributor of cannabis-based products, Tikun Olam Cannbit Pharmaceuticals Ltd., Israel (TASE:TKUN), to supply...

Via Benzinga

SciSparc Signs Agreement for the Supply of CBD-rich Cannabis Oil for its Clinical Trial on Children with Autism Spectrum Disorder

February 27, 2023

From SciSparc Ltd

Via GlobeNewswire

Jeffs' Brands To Acquire A 49% Interest In A Company That Owns A Top Seller Brand On Amazon For $2.5M ↗

February 23, 2023

Jeffs' Brands Ltd (NASDAQ: JFBR), a data-driven e-commerce company operating on the Amazon Marketplace, has entered into a definitive agreement with SciSparc Ltd.

Via Benzinga

Jeffs' Brands Entered into a Definitive Agreement to Acquire a 49% interest in a company that Owns Wellution, a Top Seller Brand on Amazon for $2.5 million

February 23, 2023

From Jeffs' Brands Ltd

Via GlobeNewswire

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.